Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""HEMORRHAGIC fever"" wg kryterium: Temat


Tytuł:
Crimean-Congo Hemorrhagic Fever Virus Diversity and Reassortment, Pakistan, 2017-2020.
Autorzy:
Umair M
Rehman Z
Whitmer S
Mobley M
Fahim A
Ikram A
Salman M
Montgomery JM
Klena JD
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 654-664.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*
Hemorrhagic Fever, Crimean*/epidemiology
Animals ; Humans ; Phylogeny ; Pakistan/epidemiology ; Sequence Analysis, DNA
Czasopismo naukowe
Tytuł:
Animal Exposure Model for Mapping Crimean-Congo Hemorrhagic Fever Virus Emergence Risk.
Autorzy:
Baz-Flores S
Jiménez-Martín D
Peralbo-Moreno A
Herraiz C
Cano-Terriza D
Cuadrado-Matías R
García-Bocanegra I
Ruiz-Fons F
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 672-680.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*
Hemorrhagic Fever, Crimean*/epidemiology
Hemorrhagic Fever, Crimean*/veterinary
Animals ; Cattle ; Sheep ; Horses ; Ruminants ; Spain/epidemiology ; Goats
Czasopismo naukowe
Tytuł:
A mRNA Vaccine for Crimean-Congo Hemorrhagic Fever Virus Expressing Non-Fusion GnGc Using NSm Linker Elicits Unexpected Immune Responses in Mice.
Autorzy:
Chen T; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Ding Z; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Li X; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Li Y; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Lan J; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.
Wong G; Viral Hemorrhagic Fever Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection (Formerly Institut Pasteur of Shanghai), Chinese Academy of Sciences, Shanghai 200031, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*
Hemorrhagic Fever, Crimean*
Humans ; Animals ; Mice ; mRNA Vaccines ; Vaccination ; Immunity, Cellular
Czasopismo naukowe
Tytuł:
Emergence of Crimean-Congo Hemorrhagic Fever Virus in Eastern Senegal in 2022.
Autorzy:
Sene O; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Sagne SN; Epidemiology, Clinical Research & Data Science, Pasteur Institute, Dakar 12900, Senegal.
Ngom D; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Diagne MM; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Badji A; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Khoulé A; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Ndiaye EH; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Sankhe S; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Loucoubar C; Epidemiology, Clinical Research & Data Science, Pasteur Institute, Dakar 12900, Senegal.
Diallo M; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Weidmann M; Institute of Microbiology and Virology, Brandenburg Medical School, 01968 Brandenburg, Germany.
Dia N; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Simon-Lorière E; G5 Evolutionary Genomics of RNA Viruses, Pasteur Institute, 75015 Paris, France.
Sall Y; Ministry of Health, Dakar 10700, Senegal.
Diop B; Ministry of Health, Dakar 10700, Senegal.
Ndiaye M; Ministry of Health, Dakar 10700, Senegal.
Sakuntabhai A; Functional Genetics of Infectious Disease Unit, Pasteur Institute, 75015 Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR2000, Department of Global Health, 75015 Paris, France.; International Vaccine Design Center (vDesC), The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo 108-8639, Japan.
Sall AA; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Faye O; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Faye O; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Diallo D; Zoology Department, Pasteur Institute, Dakar 12900, Senegal.
Barry MA; Epidemiology, Clinical Research & Data Science, Pasteur Institute, Dakar 12900, Senegal.
Fall G; WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fevers, Virology Department, Pasteur Institute, Dakar 12900, Senegal.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 19; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*/genetics
Hemorrhagic Fever, Crimean*/epidemiology
Ticks*
Animals ; Humans ; Phylogeny ; Seroepidemiologic Studies ; Senegal/epidemiology ; Livestock
Czasopismo naukowe
Tytuł:
Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Human and Livestock Populations, Northern Tanzania.
Autorzy:
Hughes EC
de Glanville W
Kibona T
Mmbaga BT
Rostal MK
Swai ES
Cleaveland S
Lankester F
Willett BJ
Allan KJ
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 836-838.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*
Humans ; Animals ; Livestock ; Cross-Sectional Studies ; Seroepidemiologic Studies ; Tanzania/epidemiology
Czasopismo naukowe
Tytuł:
Case Management of Imported Crimean-Congo Hemorrhagic Fever, Senegal, July 2023.
Autorzy:
Gueye YB
Sall Y
Roka JL
Diagne I
Sow KD
Diallo A
Dièye PS
Diallo JP
Diop B
Pasi O
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 805-807.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Crimean*/diagnosis
Hemorrhagic Fever, Crimean*/therapy
Humans ; Case Management ; Senegal/epidemiology ; Emigration and Immigration ; Health Personnel
Czasopismo naukowe
Tytuł:
Establishment of a lethal mouse model of emerging tick-borne orthonairovirus infections.
Autorzy:
Ariizumi T; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Tabata K; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.
Itakura Y; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.
Kobayashi H; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Hall WW; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; National Virus Reference Laboratory, University College Dublin, Belfield, Dublin, 4, Ireland.; Global Virus Network, Baltimore, Maryland, United States of America.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sasaki M; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.
Sawa H; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; Global Virus Network, Baltimore, Maryland, United States of America.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.
Matsuno K; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.; Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Orba Y; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 19; Vol. 20 (3), pp. e1012101. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Crimean*/pathology
Hemorrhagic Fever Virus, Crimean-Congo*
Nairovirus*
Tick-Borne Diseases*
Ticks*
Animals ; Humans ; Mice ; Disease Models, Animal ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Mice, Knockout
Czasopismo naukowe
Tytuł:
Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean-Congo hemorrhagic fever virus.
Autorzy:
Li L; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.; University of the Chinese Academy of Sciences, Beijing, China.
Chong T; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.; University of the Chinese Academy of Sciences, Beijing, China.
Peng L; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Liu Y; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Rao G; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Fu Y; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Shu Y; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Shen J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Xiao Q; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Liu J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Li J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Deng F; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Yan B; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Hu Z; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Cao S; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Wang M; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.; Hubei Jiangxia Laboratory, Wuhan, China.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Feb 01; Vol. 20 (2), pp. e1011948. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever Virus, Crimean-Congo*/genetics
Hemorrhagic Fever, Crimean*
Animals ; Mice ; Humans ; Antibodies, Monoclonal ; Cryoelectron Microscopy ; Antibodies, Neutralizing ; Epitopes
Czasopismo naukowe
Tytuł:
Spatial-temporal drivers and incidence heterogeneity of hemorrhagic fever with renal syndrome transmission in Shandong Province, China, 2016-2022.
Autorzy:
Duan Q; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Wang Y; Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; Department of Microbiological Laboratory Technology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Jiang X; Ministry of Research and Education, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Ding S; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Zhang Y; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Yao M; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Pang B; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Tian X; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China.
Ma W; Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Kou Z; Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, 250014, China. .; Infection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control, Jinan, 250014, China. .
Wen H; Department of Microbiological Laboratory Technology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Apr 13; Vol. 24 (1), pp. 1032. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever with Renal Syndrome*/epidemiology
Epidemics*
Humans ; Incidence ; China/epidemiology ; Cities
Czasopismo naukowe
Tytuł:
Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017-2019.
Autorzy:
Grayo S
Camara A
Doukouré B
Ellis I
Troupin C
Fischer K
Vanhomwegen J
White M
Groschup MH
Diederich S
Tordo N
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 681-690.
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/veterinary
Humans ; Swine ; Animals ; Guinea/epidemiology ; Sus scrofa ; Sierra Leone/epidemiology ; Nucleoproteins/genetics
Czasopismo naukowe
Tytuł:
Nephropathia Epidemica Caused by Puumala Virus in Bank Voles, Scania, Southern Sweden.
Autorzy:
Ling J
Lundeberg EE
Wasberg A
Faria IR
Vucicevic S
Settergren B
Lundkvist Å
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 732-737.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever with Renal Syndrome*/epidemiology
Hemorrhagic Fever with Renal Syndrome*/veterinary
Puumala virus*/genetics
Hantavirus Infections*
Animals ; Humans ; Sweden/epidemiology ; Arvicolinae
Czasopismo naukowe
Tytuł:
Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo.
Autorzy:
Charnley GEC; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. .; School of Public Health, Imperial College London, London, UK. .; Institute for Global Health, University College London, London, UK. .
Green N; Department of Statistical Science, University College London, London, UK.
Kelman I; Institute for Global Health, University College London, London, UK.; Institute for Risk and Disaster Reduction, University College London, London, UK.; University of Agder, Kristiansand, Norway.
Malembaka EB; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.; Centre for Tropical Diseases and Global Health (CTDGH), Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Gaythorpe KAM; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 20; Vol. 24 (1), pp. 860. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
Ebolavirus*
Humans ; Democratic Republic of the Congo/epidemiology ; Guinea/epidemiology ; Disease Outbreaks/prevention & control
Czasopismo naukowe
Tytuł:
Recent advances in the treatment of Ebola disease: A brief overview.
Autorzy:
El Ayoubi LW; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Mahmoud O; Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Zakhour J; Internal Medicine Department, Henry Ford Hospital, Detroit, Michigan, United States of America.
Kanj SS; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 15; Vol. 20 (3), pp. e1012038. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Typ publikacji:
Review; Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
Ebola Vaccines*
Ebolavirus*/genetics
Viral Vaccines*
Humans ; Antibodies, Viral ; Antibodies, Monoclonal/therapeutic use ; Uganda/epidemiology
Czasopismo naukowe
Tytuł:
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus .
Autorzy:
Cross RW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Woolsey C; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Chu VC; Gilead Sciences, Inc., Foster City, CA, USA.
Babusis D; Gilead Sciences, Inc., Foster City, CA, USA.
Bannister R; Gilead Sciences, Inc., Foster City, CA, USA.
Vermillion MS; Gilead Sciences, Inc., Foster City, CA, USA.
Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA.
Barrett KT; Gilead Sciences, Inc., Foster City, CA, USA.
Bunyan E; Gilead Sciences, Inc., Foster City, CA, USA.
Nguyen AQ; Gilead Sciences, Inc., Foster City, CA, USA.
Cihlar T; Gilead Sciences, Inc., Foster City, CA, USA.
Porter DP; Gilead Sciences, Inc., Foster City, CA, USA.
Prasad AN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Deer DJ; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Borisevich V; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Agans KN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Martinez J; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Harrison MB; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Dobias NS; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Fenton KA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA.
Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. eadk6176. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*/drug effects
Hemorrhagic Fever, Ebola*/drug therapy
Hemorrhagic Fever, Ebola*/prevention & control
Nucleosides*/administration & dosage
Nucleosides*/pharmacology
Alanine*/administration & dosage
Alanine*/analogs & derivatives
Alanine*/pharmacology
Prodrugs*/administration & dosage
Prodrugs*/pharmacology
Antiviral Agents*/administration & dosage
Antiviral Agents*/pharmacology
Animals ; Administration, Oral ; Macaca fascicularis ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/pharmacology
Czasopismo naukowe
Tytuł:
A qualitative study examining the health system's response to COVID-19 in Sierra Leone.
Autorzy:
Stone H; King's Centre for Global Health and Health Partnerships, Department of Population Health Sciences, School of Life Course and Population Sciences, King's College London, London, United Kingdom.
Bailey E; King's Centre for Global Health and Health Partnerships, Department of Population Health Sciences, School of Life Course and Population Sciences, King's College London, London, United Kingdom.; King's Sierra Leone Partnership, Connaught Hospital, Freetown, Sierra Leone.
Wurie H; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Leather AJM; King's Centre for Global Health and Health Partnerships, Department of Population Health Sciences, School of Life Course and Population Sciences, King's College London, London, United Kingdom.
Davies JI; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.; Centre for Global Surgery, Department of Global Health, Stellenbosch University, Cape Town, South Africa.; Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Bolkan HA; CapaCare, Freetown, Sierra Leone.; Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Surgery, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway.
Sevalie S; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.; Case Management Pillar, National COVID-19 Emergency Response Centre, Freetown, Sierra Leone.; 34th Military Hospital, Wilberforce, Freetown, Sierra Leone.
Youkee D; King's Sierra Leone Partnership, Connaught Hospital, Freetown, Sierra Leone.; Case Management Pillar, National COVID-19 Emergency Response Centre, Freetown, Sierra Leone.
Parmar D; King's Centre for Global Health and Health Partnerships, Department of Population Health Sciences, School of Life Course and Population Sciences, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 02; Vol. 19 (2), pp. e0294391. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
COVID-19*/epidemiology
Humans ; Sierra Leone/epidemiology ; Emergencies ; Qualitative Research ; Disease Outbreaks/prevention & control
Czasopismo naukowe
Tytuł:
Computational and stability analysis of Ebola virus epidemic model with piecewise hybrid fractional operator.
Autorzy:
Nisar KS; Department of Mathematics, College of Arts and Sciences, Prince Sattam bin Abdulaziz University, Wadi Aldawaser, Saudi Arabia.
Farman M; Faculty of Arts and Sciences, Department of Mathematics, Near East University, Nicosia, Northern Cyprus, Turkey.; Department of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon.
Jamil K; Institute of Mathematics, Khwaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan.
Akgul A; Faculty of Arts and Science, Department of Mathematics, Siirt University, Siirt, Turkey.
Jamil S; Institute of Mathematics, Khwaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0298620. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*
Hemorrhagic Fever, Ebola*/epidemiology
Epidemics*
Humans ; Learning ; Public Health
Czasopismo naukowe
Tytuł:
Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions .
Autorzy:
Bus-Jacobs L
Lau R
Soethoudt M
Gebbia L
Janssens E
Hermans T
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 757-760.
Typ publikacji:
Journal Article
MeSH Terms:
Ebola Vaccines*
Hemorrhagic Fever, Ebola*/prevention & control
Ebolavirus*
Humans ; Vibration ; Computer Simulation ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Scalable gradients enable Hamiltonian Monte Carlo sampling for phylodynamic inference under episodic birth-death-sampling models.
Autorzy:
Shao Y; Department of Biostatistics, University of California, Los Angeles, California, United States of America.
Magee AF; Department of Biomathematics, University of California, Los Angeles, California, United States of America.
Vasylyeva TI; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.; Department of Population Health and Disease Prevention, University of California Irvine, Irvine, California, United States of America.
Suchard MA; Department of Biostatistics, University of California, Los Angeles, California, United States of America.; Department of Biomathematics, University of California, Los Angeles, California, United States of America.; Department of Human Genetics, Universtiy of California, Los Angeles, California, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Mar 29; Vol. 20 (3), pp. e1011640. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Epidemics*
Hemorrhagic Fever, Ebola*/epidemiology
Humans ; Influenza A Virus, H3N2 Subtype ; Algorithms ; Monte Carlo Method
Czasopismo naukowe
Tytuł:
Species-specific responses during Seoul orthohantavirus infection in human and rat lung microvascular endothelial cells.
Autorzy:
Noack D; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
van den Hout MCGN; Department of Cell Biology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Embregts CWE; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
van IJcken WFJ; Department of Cell Biology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Koopmans MPG; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rockx B; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Mar 27; Vol. 18 (3), pp. e0012074. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Seoul virus*/genetics
Hantavirus Infections*
Hemorrhagic Fever with Renal Syndrome*
Humans ; Rats ; Animals ; Endothelial Cells ; Seoul ; Lung ; Rodentia ; Antiviral Agents
Czasopismo naukowe
Tytuł:
Ebola virus disease sequelae and viral persistence in animal models: Implications for the future.
Autorzy:
Durant O; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 21; Vol. 20 (3), pp. e1012065. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*
Ebolavirus*
Animals ; Disease Outbreaks ; Disease Progression ; Disease Models, Animal
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies